R&D Candidate definition

R&D Candidate has the meaning given to such term in the Collaboration Agreement.
Sample 1Sample 2
R&D Candidate. Research and Development Candidate or R&D Candidate shall mean any Antibody to a Specific Target (other than a CAT Exclusive Antibody) that the Joint Steering Committee designates as a R&D Candidate by determining that such Antibody should proceed with GLP toxicology studies.
Sample 1Sample 2

Examples of R&D Candidate in a sentence

  • First, wait as long as you possibly can; some systems can take up to 120 seconds to register this file.

  • Review, analyze and update if needed, the identified gaps which may be hindering the effective implementation of the land use planning process so as to avoid insensitive infrastructure development, conversion of productive lands, poor range and farmland management practices, and encroachment on natural ecosystems especially forests (Gaps identified under the UNDP/SLMQ project, and will be shared with the consultant)2.

  • Notwithstanding the foregoing, to the extent CAT has or receives any information regarding any adverse drug experience which may be related to the use of any R&D Candidate or Collaboration Product, CAT shall promptly provide ELAN with all such information in accordance with the adverse event reporting procedures to be established by the JSC no later than [***] (as may be amended from time to time upon mutual agreement of the Parties).

  • Each Party shall use, and shall cause its permitted Third Party Sublicensees to use, commercially reasonable and diligent efforts to disclose to the other Party all material information relating to any R&D Candidate or Collaboration Product promptly after it is learned or its materiality appreciated.

  • Within [***] after the date first written above, the Parties shall prepare a written annual research plan (the "Annual Research Plan") for the Research activities to be conducted with respect to each Specific Target, any Antibody candidate which bind thereto and each R&D Candidate.

  • Ms. Armstrong testified about the public interest factors the Commission is to consider under Ind.

  • From time to time, either Party may request an affirmation from the other Party of the status of an Antibody as either an CAT Exclusive Antibody or an R&D Candidate.

  • An R&D Candidate shall remain in the Development Program until such time as (i) the JSC determines that such R&D Candidate should be returned to the Research Program for the conduct of further Research, (ii) such R&D Candidate is dropped from the Development Program or (iii) such R&D Candidate becomes a Collaboration Product.

  • Within [***] after the date first written above, ELAN and CAT shall establish a "Joint Steering Committee" or "JSC" to oversee and direct the conduct of Research and the Development of each Specific Target and R&D Candidate and to oversee and coordinate those activities that are necessary for the successful Commercialization for a Collaboration Product in the Territory, as further described below in this Agreement.

  • On a Collaboration Product-by-Collaboration Product basis, not later than [***] after commencement of the first Phase III Clinical Trial of a R&D Candidate in the Territory, ELAN shall prepare and the JSC shall review, and after due consideration by ELAN of any suggestions or comments, accept ELAN's rolling multi-year (being not less than[***]) plan for Commercializing the Collaboration Product in the Territory (the "Commercialization Plan"), which plan shall include without limitation [***].

Related to R&D Candidate

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Compound means [***].

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Research Program has the meaning set forth in Section 2.1.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • GSK will have the meaning set forth in the Preamble.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • hit means the existence of a match or matches established by the Central System by comparison between biometric […] data recorded in the computerised central database and those transmitted by a Member State with regard to a person, without prejudice to the requirement that Member States shall immediately check the results of the comparison pursuant to Article 26(4);

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Valid write-in candidate means a candidate who has qualified as a write-in